To address the growing demand for R&D of prospective remedies for the management of vascular brain injury, we have proposed a mouse model (B6D2F1/J mice) of CI-induced intracranial hemorrhage and tested the influence of ghrelin on incidents of brain hemorrhagic lesions. The gene discussed is GHRL; the disease is intracranial hemorrhage.